Xiao Wang
Moderator
Dr. Wang is a Partner at Avant Blockchain Capital, a venture fund investing in Web3 technology companies. Dr. Wang has over eight years of experiences in the venture capital industry acting as a general partner of InnoSpring Seed Fund II, focusing on early stage technology investments in Silicon Valley. Dr. Wang also holds the Venture Partner position at Particle Future VC, an early to growth stage venture capital firm focusing on hard tech investments in US and Asia. Her portfolio success includes Theta ($15B market cap ATH), Pluralsight (NASDAQ:PS, $3.5B market cap), Plushcare (acquired for $550M), Securly (acquired for $230M) etc.
Prior to her venture capital career, Dr. Wang cofounded and held the CEO position of Innospring Silicon Valley, a prominent cross border US-China tech incubator. Dr. Wang graduated from Tsinghua University, and obtained her PhD degree from Case Western Reserve University majoring in Biochemistry.
Dr Wang’s work was recognized for:
- Top 10 Global accelerators
- Top 5 Chinese tech giants investing in SV
- Top 5 Chinese VC in SV
- 2018 Women of Influence - Silicon Valley
Dr. Wang is an expert on US-China cross border investments and entrepreneurship, and regularly speaks on these topics. Xiao has presented or moderated on topics such as Early-Stage Tech Ecosystems in China, Investments and Incubators and Sexy or Unsexy Investments at Stanford, MIT-China Innovation Entrepreneurship Forum and the Sync US China conference. Dr. Wang earned her Ph.D. in Biochemistry from Case Western Reserve University in Cleveland, OH, and her B.S. in Biological Sciences from Tsinghua University in Beijing, China.
